Highlights in Lung Cancer, 2012: ALK Inhibitors for Patients with ALK or ROS1 Gene Rearrangements (audio)

Highlights in Lung Cancer, 2012: ALK Inhibitors for Patients with ALK or ROS1 Gene Rearrangements (audio)

Desde: GRACEcast
0 0 hace 7 años
00:00
10:36
Medicina, #2012, #advanced, #alk, #cancer, #cancergrace, #eml4alk, #grace, #highlights, #hospital, #in, #lung, #margaret, #mutation, #natasha, #nsclc, #of, #princess, #rearrangement, #toronto, #university
Dr. Natasha Leighl, Princess Margaret Hospital in Toronto, Canada, describes emerging data on the efficacy of ALK inhibitors for patients with advanced NSCLC that harbors an ALK or ROS1 rearrangement.

Autor

cancerGRACE Meetings
cancerGRACE Meetings 2 followers Follow

Síguenos en Facebook

Spreaker logo
  • Elegir idioma

Para podcasters y editores

Herramientas para podcasters

Para oyentes

Copyright 2021 - Spreaker Inc. a Voxnest Company - Crear un Podcast - New York, NY